Author

José Francisco Fernandes

Observed names: Fernandes, Jose F., Fernandes, José, Fernandes, José F, Jose F Fernandes, Jose Fernandes, Jose Francisco Fernandes, José F Fernandes, José F. FERNANDES, José F. Fernandes, José Fernandes

Institutions: Centre de Recherche Médicales de Lambaréné, University Hospital of Geneva, German Center for Infection Research, Amsterdam Public Health, Amsterdam University Medical Centers, University of Tübingen, University of Amsterdam

Observed institutions: Albert Schweitzer Hospital, Philipps University of Marburg, Amsterdam UMC Location University of Amsterdam, Universitätsklinikum Tübingen, Centre de Recherche Médicales de Lambaréné, University Hospital of Geneva, University Medical Center Hamburg-Eppendorf, German Center for Infection Research, Amsterdam Public Health, Amsterdam University Medical Centers, Medical University of Vienna, University of Tübingen, University of Amsterdam, Bernhard Nocht Institute for Tropical Medicine

ORCID: 0000-0001-5250-1219

Observed ORCID: 0000-0001-5250-1219

OpenAlex ID: A5101677369

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

2015 · Emmanuel B. Bache, Sélidji Todagbé Agnandji, et al. · The Lancet · 642

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

2015 · Selidji T. Agnandji, Angela Huttner, et al. · New England Journal of Medicine · 413

PDF

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

2011 · Kwaku Poku Asante, Salim Abdulla, et al. · The Lancet Infectious Diseases · 136

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

2018 · Angela Huttner, Selidji Todagbe Agnandji, et al. · The Lancet Infectious Diseases · 82

Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2

2018 · Jean Claude Dejon-Agobe, Ulysse Ateba-Ngoa, et al. · Clinical Infectious Diseases · 74

PDF

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01EMalaria Candidate Vaccine When Integrated in the Expanded Program of Immunization

2010 · Selidji T. Agnandji, Kwaku Poku Asante, et al. · The Journal of Infectious Diseases · 73

Epidemiology and population structure of Staphylococcus aureus in various population groups from a rural and semi urban area in Gabon, Central Africa

2012 · Ulysse Ateba Ngoa, Frieder Schaumburg, et al. · Acta Tropica · 70

Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries

2017 · Chris Drakeley, Salim Abdulla, et al. · Malaria Journal · 68

PDF

Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial

2017 · Selidji T. Agnandji, José F. Fernandes, et al. · PLoS Medicine · 68

PDF

Clinical Development of RTS,S/AS Malaria Vaccine: A Systematic Review of Clinical Phase I–III Trials

2015 · Selidji T Agnandji, José F Fernandes, et al. · Future Microbiology · 49

Fosmidomycin as an Antimalarial Drug: A Meta-Analysis of Clinical Trials

2015 · Jose Francisco Fernandes, Bertrand Lell, et al. · Future Microbiology · 49

Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative

2018 · Jacqueline Kyungah Lim, Mabel Carabali, et al. · BMJ Open · 35

PDF

Distinct Helper T Cell Type 1 and 2 Responses Associated With Malaria Protection and Risk in RTS,S/AS01E Vaccinees

2017 · Gemma Moncunill, Maxmillian Mpina, et al. · Clinical Infectious Diseases · 32

PDF

Effect of Antihelminthic Treatment on Vaccine Immunogenicity to a Seasonal Influenza Vaccine in Primary School Children in Gabon: A Randomized Placebo-Controlled Trial

2015 · Sina Brückner, Selidji T. Agnandji, et al. · PLoS neglected tropical diseases · 30

PDF

Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability

2023 · Angela Huttner, Selidji Todagbe Agnandji, et al. · Clinical Microbiology and Infection · 25

PDF

Regional Variation of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales, Fluoroquinolone-Resistant Salmonella enterica and Methicillin-Resistant Staphylococcus aureus Among Febrile Patients in Sub-Saharan Africa

2020 · Rehema Moraa Moirongo, Eva Lorenz, et al. · Frontiers in Microbiology · 24

PDF

Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination

2020 · David Pejoski, Casimir de Rham, et al. · npj Vaccines · 19

PDF

Molecular epidemiology of respiratory syncytial virus in children in sub‐Saharan Africa

2021 · Clara Marlene Ihling, Paul Schnitzler, et al. · Tropical Medicine & International Health · 14

PDF

Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay

2015 · Maria Rebelo, Carolina Tempera, et al. · Malaria Journal · 13

PDF

Epidemiology of dengue fever in Gabon: Results from a health facility-based fever surveillance in Lambaréné and its surroundings

2021 · Jacqueline Kyungah Lim, José Francisco Fernandes, et al. · PLoS neglected tropical diseases · 11

PDF

Unbiased metagenomic next-generation sequencing of blood from hospitalized febrile children in Gabon

2020 · José Francisco Fernandes, Florian Laubscher, et al. · Emerging Microbes & Infections · 11

PDF

A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children

2016 · Sina Brückner, Selidji Todagbe Agnandji, et al. · Vaccine · 11

Causes of fever in Gabonese children: a cross-sectional hospital-based study

2020 · José Francisco Fernandes, Jana Held, et al. · Scientific Reports · 10

PDF

Current status of the clinical development and implementation of paediatric artemisinin combination therapies in Sub-Saharan Africa

2011 · Selidji Todagbe Agnandji, Florian Kurth, et al. · Wiener klinische Wochenschrift · 8

The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel

2011 · Selidji T Agnandji, Florian Kurth, et al. · Malaria Journal · 4

PDF

Works count: 36

Citation count: 2,054

H-index: 18

I10-index: 24